📰 Abt News
Page 125 - Abt News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Abt. Real-time updates on events, politics, business and more.
July 29, 2023
Achmea Investment Management B.V. increased its stake in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 9.8% in the first quarter, according to its most recent Form 13F filing with the SEC. The fund owned 116,766 shares of the healthcare product maker’s stock after buying an additional 10,398 shares during the period. Achmea Investment […]
July 28, 2023
Axxcess Wealth Management LLC grew its position in Abbott Laboratories (NYSE:ABT – Free Report) by 0.1% during the 1st quarter, HoldingsChannel.com reports. The firm owned 67,081 shares of the healthcare product maker’s stock after acquiring an additional 98 shares during the quarter. Axxcess Wealth Management LLC’s holdings in Abbott Laboratories were worth $6,793,000 as of […]
July 28, 2023
Curi Wealth Management LLC reduced its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 19.4% during the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 76,107 shares of the healthcare product maker’s stock after selling 18,332 shares during the quarter. Curi Wealth […]
July 28, 2023
Lyell Wealth Management LP decreased its stake in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 6.4% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The fund owned 62,260 shares of the healthcare product maker’s stock after selling 4,245 shares during the period. Lyell Wealth Management LP’s […]
July 27, 2023
Abbott Laboratories (NYSE:ABT – Free Report) had its price target lifted by Barclays from $127.00 to $132.00 in a report issued on Monday, MarketBeat reports. Barclays currently has an overweight rating on the healthcare product maker’s stock. Several other analysts have also recently weighed in on ABT. Raymond James lifted their price objective on Abbott […]
July 27, 2023
ASB Consultores LLC reduced its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 7.8% in the 1st quarter, HoldingsChannel reports. The institutional investor owned 2,440 shares of the healthcare product maker’s stock after selling 206 shares during the quarter. ASB Consultores LLC’s holdings in Abbott Laboratories were worth $247,000 at the end of the […]
July 27, 2023
J.W. Cole Advisors Inc. raised its position in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 13.1% in the first quarter, HoldingsChannel reports. The firm owned 21,341 shares of the healthcare product maker’s stock after acquiring an additional 2,466 shares during the period. J.W. Cole Advisors Inc.’s holdings in Abbott Laboratories were worth $2,161,000 […]
July 27, 2023
Anchor Capital Advisors LLC lessened its position in Abbott Laboratories (NYSE:ABT – Free Report) by 0.3% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 142,703 shares of the healthcare product maker’s stock after selling 407 shares during the quarter. […]
July 25, 2023
Arcblock (ABT) traded down 2.2% against the dollar during the 1 day period ending at 22:00 PM Eastern on July 24th. Arcblock has a total market cap of $8.54 million and approximately $248,326.70 worth of Arcblock was traded on exchanges in the last day. One Arcblock token can now be purchased for approximately $0.0866 or […]
July 25, 2023
Arcblock (ABT) traded 1.4% higher against the US dollar during the 1 day period ending at 10:00 AM ET on July 25th. Arcblock has a total market cap of $8.63 million and $151,243.06 worth of Arcblock was traded on exchanges in the last day. One Arcblock token can currently be purchased for about $0.0876 or […]